Advertisement
Screener

IMMURON LIMITED (IMRN) Increase Decrease In Cash And Cash Equivalents

2.8 / 5 stars · 68/120 Roast Me

IMMURON LIMITED Increase Decrease In Cash And Cash Equivalents

IMMURON LIMITED (IMRN) reported Increase Decrease In Cash And Cash Equivalents of -AUD 8.84 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-25.

Financial Statements › Notes

ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2025-09-25

AUD

Period endIncrease Decrease In Cash And Cash Equivalents 12 month
2025-06-30-8.84M AUD
20-F · filed 2025-09-25
2024-06-30-5.55M AUD
20-F · filed 2025-09-25
2023-06-30-5.26M AUD
20-F · filed 2025-09-25
2022-06-30-3.18M AUD
20-F · filed 2024-10-01
2021-06-3022.40M AUD
20-F · filed 2023-09-28
2020-06-30-1.99M AUD
20-F · filed 2022-09-09
2019-06-30268.60K AUD
20-F · filed 2021-10-29
2018-06-30839.15K AUD
20-F · filed 2020-10-28
2017-06-301.66M AUD
20-F · filed 2019-10-28
2016-06-30-825.43K AUD
20-F · filed 2018-10-31

USD

Period endIncrease Decrease In Cash And Cash Equivalents 6 month
2023-12-31-$1.87M
6-K/A · filed 2024-05-28
2022-12-31-$3.62M
6-K/A · filed 2024-05-28
2019-12-31-$302.21K
6-K/A · filed 2020-06-19
2018-12-31-$424.90K
6-K/A · filed 2020-06-19